Q&A With Dr David Ali From Memphasys Reproductive Biotechnology (ASX:MEM)

Spacetalk Keeps Momentum Alive with ARR Surge and Strategic Growth

4DS Memory: Cash Injection Powers Next Phase of ReRAM Development

Visioneering receives positive interim two-year data from PROTECT trial

Dimerix recruits first paediatric patient for ACTION3

Memphasys Celebrates Landmark Publication on RoXsta™ Diagnostic System

Nanoveu's EMASS achieves ultra-low power fall detection with ECS chip

Immuron signs Monash AMR research collaboration

Rhythm Bioscience acquires Genetype genetic risk assessment business

Atomo Diagnostics secures long term agreement with Newfoundland

MTM Critical Metals: Pitt Street Research Points to a Transformative 2025

Staff Writers 12 June, 2023

Pharmaceuticals

SHARE
SHARE

Rate video from Staff Writers: